Article

IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Veterinary Molecular Biology, Montana State University, Bozeman, Montana, United States of America.
PLoS ONE (Impact Factor: 3.53). 01/2010; 5(1):e8720. DOI: 10.1371/journal.pone.0008720
Source: PubMed

ABSTRACT Conventional methods to induce tolerance in humans have met with limited success. Hence, efforts to redirect tolerogen uptake using reovirus adhesin, protein sigma 1 (psigma1), may circumvent these shortcomings based upon the recent finding that when reovirus psigma1 is engineered to deliver chicken ovalbumin (OVA) mucosally, tolerance is obtained, even with a single dose. To test whether single-dose tolerance can be induced to treat EAE, proteolipid protein (PLP(130-151)) was genetically fused to OVA to psigma1 (PLP:OVA-psigma1) and shown to significantly ameliorate EAE, suppressing proinflammatory cytokines by IL-10(+) forkhead box P3 (FoxP3)(+) CD25(+)CD4(+) T(reg) and IL-4(+)CD25(-)CD4(+) Th2 cells. IL-10R or IL-4 neutralization reversed protection to EAE conferred by PLP:OVA-psigma1, and adoptive transfer of Ag-specific T(reg) or Th2 cells restored protection against EAE in recipients. Upon assessment of each relative participant, functional inactivation of CD25 impaired PLP:OVA-psigma1's protective capacity, triggering TGF-beta-mediated inflammation; however, concomitant inactivation of TGF-beta and CD25 reestablished PLP:OVA-psigma1-mediated protection by IL-28-producing FoxP3(+)CD25(-)CD4(+) T cells. Thus, psigma1-based therapy can resolve EAE independently of or dependently upon CD25 and assigns IL-28 as an alternative therapy for autoimmunity.

Download full-text

Full-text

Available from: Javier Ochoa-Repáraz, May 01, 2014
0 Followers
 · 
154 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To assess the potency of regulatory T (Treg) cells induced against an irrelevant Ag, mice were orally vaccinated with Salmonella expressing Escherichia coli colonization factor antigen I fimbriae. Isolated CD25⁺ and CD25⁻CD4⁺ T cells were adoptively transferred to naive mice, and Treg cells effectively protected against experimental autoimmune encephalomyelitis (EAE), unlike Treg cells from Salmonella vector-immunized mice. This protection was abrogated upon in vivo neutralization of TGF-β, resulting in elevated IL-17 and loss of IL-4 and IL-10 production. Thus, Treg cells induced to irrelevant Ags offer a novel approach to treat autoimmune diseases independent of auto-Ag.
    Journal of neuroimmunology 03/2012; 245(1-2):39-47. DOI:10.1016/j.jneuroim.2012.02.003 · 2.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ground target head-tracking performance is used to empirically specify limits of gaze control during passive flight in a virtual world. The data indicate that head-tracking error is related directly to total angular velocity of the target. Simulation modeling of the optic flow demonstrates the differences between conventional optic flow with a fixed gaze and differential optic flow with a tracking gaze. Potential processing pathways are proposed for both the tracking function and the flight control function
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Type III interferons, also known as IFN-lambda or IL-28/29, are a recently discovered family of IFNs related to both the type I IFNs and interleukin-10 family members. Interferon-lambda is functionally an interferon but structurally it is related to the interleukin-10 family. These novel cytokines are directly induced during viral infection like type-I interferons and signal through a similar JAK-STAT signaling pathway as type I IFN to activate the transcription of a similar set of IFN-stimulated genes (ISG) but use a separate receptor complex. ISG product induced by the type III family of IFNs are associated with immunomodulatory ability, antiviral activity and other effects. The antiviral and immunomodulatory effects of type III interferons make them interesting therapeutics for clinical use. In this review, we summarize the current state of knowledge about the biology of IFN-lambdas and their roles in immune responses via immunomodulatory and antiviral activity.
    Postępy Higieny i Medycyny Doświadczalnej (Advances in Hygiene and Experimental Medicine) 01/2010; 64:522-33. · 0.63 Impact Factor